• 제목/요약/키워드: Whallak-tang

검색결과 3건 처리시간 0.021초

활락탕(活絡湯)의 NO 억제, DPPH 소거 및 Microarray상 유전자 발현에 미치는 영향 (Inhibitory Effect on NO, Scavenging Effect on DPPH Radical in Whallak-tang)

  • 김철홍;윤현민;장경전;송춘호;안창범
    • Journal of Acupuncture Research
    • /
    • 제21권5호
    • /
    • pp.69-78
    • /
    • 2004
  • Objective : This study was undertaken to determine the inhibitory effect of Whallak-tang against Nitric Oxide, the scavenging effect of Whallak-tang on DPPH radical. Methods : Both nitric concentration 1, 3, 6 and 24 hours after treatment with Vit. C and Whallak-tang at 0.1, 1, 10 mg/ml and scavenging effect 10, 20, 30 and 60 minute after treatment with Vit. C and Whallak-tang at 0.1, 1, 10 mg/ml were estimated. Results : The inhibitory effect of Whallak-tang against Nitric Oxide was dose-dependent. The scavenging effect of Whallak-tang on DPPH radical was dose-dependent. Conclusion : These results would provide important basic data on the possibility of the clinical treatment of Whallak-tang in musculoskeletal disease.

  • PDF

활락탕을 투여한 편타성 손상 증후군 환자 치험 2례 (A Case Report of Prescribing Whallak-tang(Huoluo-tang) for the two patients with Whiplash injury)

  • 엄봉군;조태영;정영훈;이차로;이재영;안영태
    • 척추신경추나의학회지
    • /
    • 제5권1호
    • /
    • pp.125-136
    • /
    • 2010
  • 활락탕을 처방하여 편타성 손상으로 경부 및 상지에 극심한 통증이 호전된 2례를 통해 편타성 손상의 초기 단계인 경우(1-10 일(日)) 활혈거어지제(活血祛瘀之劑)를 사용하게 되는데 초기 극심한 통증 제어 및 치료에 활락탕이 유효한 효과가 있었음을 확인하였다. 이에 저자는 본원에 편타성 손상증후군으로 입원하여 활락탕을 복용 한 뒤 호전된 2케이스를 보고하고자 한다.

  • PDF

활락탕(活絡湯)의 cDNA Microarray를 이용한 유전자 발현에 미치는 영향 (Genes expression by using cDNA Microarray in Whallak-tang)

  • 신철경;이채우;유선애;윤현민;장경전;송춘호;안창범;김철홍
    • 대한약침학회지
    • /
    • 제11권4호
    • /
    • pp.5-14
    • /
    • 2008
  • Objective This study was undertaken to determine the effect of Whallak-tang on expression of CD/cytokine Genes. Methods The expression of CD/Cytokine Genes were examined by cDNA microarray using the human mast cell line(HMC-1). Results The expression of ATP5F1, FLJ20671, unknown, KIAA0342, OAS2, unknown genes were increased in $200{\sim}300%$ range. The expression of unknown, MDS006, IFITM1, MRPL3, ZNF207, FTH1, FBP1, NRGN, NR1H2, KIAA0747 genes were decreased in $0{\sim}33%$ range. Conclusion These results would provide important basic data on the possibility of the clinical treatment of Whallak-tang in musculoskeletal disease.